Drug intelligence / Profile preview

N,N-diethyl-2-[(2-thienylcarbonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide

Development stage
Unknown
Modality
Small Molecules
01

Overview

N,N-diethyl-2-[(2-thienylcarbonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide is an experimental small molecule belonging to the class of thiophene carboxamides. It has a molecular formula of C18H22N2O2S2 and a molecular weight of approximately 362.51 g/mol[1][4][5]. The compound is not approved for medical use in any jurisdiction and has no known clinical indications or completed clinical trials[1]. It is primarily used as a research tool and has been identified as a potent inhibitor of kinesin-like protein 1 (KIF11), which plays an essential role in mitotic spindle formation during cell division[7]. Its mechanism suggests potential utility in cancer research or other areas involving cell proliferation.

Other names
N,N-diethyl-2-(thiophen-2-carbonylamino)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamideN,N-diethyl[2-(2-thienylcarbonylamino)(4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)]carboxamide301321-93-7
02

Targets

KIF11 (Kinesin Spindle Protein)

Beyond the preview

Go deeper on N,N-diethyl-2-[(2-thienylcarbonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N,N-diethyl-2-[(2-thienylcarbonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call